Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' MECHOULAM R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 77 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rubnov, S; Kashman, Y; Rabinowitz, R; Schlesinger, M; Mechoulam, R
      Suppressors of cancer cell proliferation from fig (Ficus carica) resin: Isolation and structure elucidation

      JOURNAL OF NATURAL PRODUCTS
    2. Panikashvili, D; Simeonidou, C; Ben-Shabat, S; Hanus, L; Breuer, A; Mechoulam, R; Shohami, E
      An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

      NATURE
    3. Mechoulam, R; Fride, E
      A hunger for cannabinoids

      NATURE
    4. Hanus, L; Abu-Lafi, S; Fride, E; Breuer, A; Vogel, Z; Shalev, DE; Kustanovich, I; Mechoulam, R
      2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1receptor

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    5. Fride, E; Ginzburg, Y; Breuer, A; Bisogno, T; Di Marzo, V; Mechoulam, R
      Critical role of the endogenous cannabinoid system in mouse pup suckling and growth

      EUROPEAN JOURNAL OF PHARMACOLOGY
    6. Bisogno, T; Hanus, L; De Petrocellis, L; Tchilibon, S; Ponde, DE; Brandi, I; Moriello, AS; Davis, JB; Mechoulam, R; Di Marzo, V
      Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

      BRITISH JOURNAL OF PHARMACOLOGY
    7. Tchilibon, S; Mechoulam, R
      Synthesis of a primary metabolite of cannabidiol

      ORGANIC LETTERS
    8. Mechoulam, R
      Looking back at Cannabis research

      CURRENT PHARMACEUTICAL DESIGN
    9. Naveh, N; Weissman, C; Muchtar, S; Benita, S; Mechoulam, R
      A submicron emulsion of HU-211, a synthetic cannabinoid, reduces intraocular pressure in rabbits

      GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    10. Shohami, E; Mechoulam, R
      Dexanabinol (HU-211): A nonpsychotropic cannabinoid with neuroprotective properties

      DRUG DEVELOPMENT RESEARCH
    11. Mechoulam, R
      The science of marijuana

      NATURE
    12. Malfait, AM; Gallily, R; Sumariwalla, PF; Malik, AS; Andreakos, E; Mechoulam, R; Feldmann, M
      The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    13. Gallily, R; Breuer, A; Mechoulam, R
      2-arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    14. Hao, SZ; Avraham, Y; Mechoulam, R; Berry, EM
      Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    15. Chen, Y; McCarron, RM; Ohara, Y; Bembry, J; Azzam, N; Lenz, FA; Shohami, E; Mechoulam, R; Spatz, M
      Human brain capillary endothelium - 2-arachidonoglycerol (endocannabinoid)interacts with endothelin-1

      CIRCULATION RESEARCH
    16. Mechoulam, R; Hanus, L
      A historical overview of chemical research on cannabinoids

      CHEMISTRY AND PHYSICS OF LIPIDS
    17. Mechoulam, R
      Recent advances in cannabinoid research

      FORSCHENDE KOMPLEMENTARMEDIZIN
    18. Mechoulam, R; Ben-Shabat, S
      From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis

      NATURAL PRODUCT REPORTS
    19. Hanus, L; Breuer, A; Tchilibon, S; Shiloah, S; Goldenberg, D; Horowitz, M; Pertwee, RG; Ross, RA; Mechoulam, R; Fride, E
      HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    20. Martin, BR; Mechoulam, R; Razdan, RK
      Discovery and characterization of endogenous cannabinoids

      LIFE SCIENCES
    21. Mechoulam, R; Devane, WA; Glaser, R
      Cannabinoid geometry and biological activity

      MARIHUANA AND MEDICINE
    22. SULCOVA E; MECHOULAM R; FRIDE E
      BIPHASIC EFFECTS OF ANANDAMIDE

      Pharmacology, biochemistry and behavior
    23. Mechoulam, R; Hanus, L; Fride, E
      Towards cannabinoid drugs - revisited

      PROGRESS IN MEDICINAL CHEMISTRY 35
    24. Di Marzo, V; Sepe, N; De Petrocellis, L; Berger, A; Crozier, G; Fride, E; Mechoulam, R
      Trick or treat from food endocannabinoids?

      NATURE
    25. MECHOULAM R; FRIDE E; DIMARZO V
      ENDOCANNABINOIDS

      European journal of pharmacology
    26. BENSHABAT S; FRIDE E; SHESKIN T; TAMIRI T; RHEE MH; VOGEL Z; BISOGNO T; DEPETROCELLIS L; DIMARZO V; MECHOULAM R
      AN ENTOURAGE EFFECT - INACTIVE ENDOGENOUS FATTY-ACID GLYCEROL ESTERS ENHANCE 2-ARACHIDONOYL-GLYCEROL CANNABINOID ACTIVITY

      European journal of pharmacology
    27. Mechoulam, R; Fride, E; Ben-Shabat, S; Meiri, U; Horowitz, M
      Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid

      EUROPEAN JOURNAL OF PHARMACOLOGY
    28. SHOHAMI E; GALLILY R; MECHOULAM R; BASS R; BENHUR T
      CYTOKINE PRODUCTION IN THE BRAIN FOLLOWING CLOSED-HEAD INJURY - DEXANABINOL (HU-211) IS A NOVEL TNF-ALPHA INHIBITOR AND AN EFFECTIVE NEUROPROTECTANT

      Journal of neuroimmunology
    29. MECHOULAM R; FRIDE E; HANUS L; SHESKIN T; BISOGNO T; DIMARZO V; BAYEWITCH M; VOGEL Z
      ANANDAMIDE MAY MEDIATE SLEEP INDUCTION

      Nature
    30. MECHOULAM R
      TODDS ACHIEVEMENT

      Nature
    31. GALLILY R; YAMIN A; WAKSMANN Y; OVADIA H; WEIDENFELD J; BARJOSEPH A; BIEGON A; MECHOULAM R; SHOHAMI E
      PROTECTION AGAINST SEPTIC SHOCK AND SUPPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA AND NITRIC-OXIDE PRODUCTION BY DEXANABINOL (HU-211), A NONPSYCHOTROPIC CANNABINOID

      The Journal of pharmacology and experimental therapeutics
    32. SHESKIN T; HANUS L; SLAGER J; VOGEL Z; MECHOULAM R
      STRUCTURAL REQUIREMENTS FOR BINDING OF ANANDAMIDE-TYPE COMPOUNDS TO THE BRAIN CANNABINOID RECEPTOR

      Journal of medicinal chemistry
    33. RHEE MH; VOGEL Z; BARG J; BAYEWITCH M; LEVY R; HANUS L; BREUER A; MECHOULAM R
      CANNABINOL DERIVATIVES - BINDING TO CANNABINOID RECEPTORS AND INHIBITION OF ADENYLYLCYCLASE

      Journal of medicinal chemistry
    34. BISOGNO T; SEPE N; DEPETROCELLIS L; MECHOULAM R; DIMARZO V
      THE SLEEP-INDUCING FACTOR OLEAMIDE IS PRODUCED BY MOUSE NEUROBLASTOMA-CELLS

      Biochemical and biophysical research communications
    35. WILSON RG; TAHIR SK; MECHOULAM R; ZIMMERMAN S; ZIMMERMAN AM
      CANNABINOID ENANTIOMER ACTION ON THE CYTOARCHITECTURE

      Cell biology international
    36. MECHOULAM R; BENSHABAT S; HANUS L; FRIDE E; VOGEL Z; BAYEWITCH M; SULCOVA AE
      ENDOGENOUS CANNABINOID LIGANDS - CHEMICAL AND BIOLOGICAL STUDIES

      Journal of lipid mediators and cell signalling
    37. POP E; SOTI F; BREWSTER ME; BARENHOLZ Y; KORABLYOV V; MECHOULAM R; NADLER V; BIEGON A
      DERIVATIVES OF DEXANABINOL .2. SALTS OF AMINO-ACID ESTERS CONTAINING TERTIARY AND QUATERNARY HETEROCYCLIC NITROGEN WITH INCREASED WATER-SOLUBILITY

      Pharmaceutical research
    38. POP E; LIU ZZ; BREWSTER ME; BARENHOLZ Y; KORABLYOV V; MECHOULAM R; NADLER V; BIEGON A
      DERIVATIVES OF DEXANABINOL .1. WATER-SOLUBLE SALTS OF GLYCINATE ESTERS

      Pharmaceutical research
    39. FRIDE E; MECHOULAM R
      DEVELOPMENTAL ASPECTS OF ANANDAMIDE - ONTOGENY OF RESPONSE AND PRENATAL EXPOSURE

      Psychoneuroendocrinology
    40. MECHOULAM R
      ENDOGENOUS CANNABINOID LIGANDS

      Journal of neuroimmunology
    41. FRIDE E; MECHOULAM R
      ONTOGENIC DEVELOPMENT OF THE RESPONSE TO ANANDAMIDE AND DELTA(9)-TETRAHYDROCANNABINOL IN MICE

      Developmental brain research
    42. BAYEWITCH M; RHEE RH; AVIDORREISS T; BREUER A; MECHOULAM R; VOGEL Z
      (-)-DELTA(9)-TETRAHYDROCANNABINOL ANTAGONIZES THE PERIPHERAL CANNABINOID RECEPTOR-MEDIATED INHIBITION OF ADENYLYL-CYCLASE

      The Journal of biological chemistry
    43. ZUARDI AW; MORAIS SL; GUIMARAES FS; MECHOULAM R
      ANTIPSYCHOTIC EFFECT OF CANNABIDIOL

      The Journal of clinical psychiatry
    44. OVADIA H; WOHLMAN A; MECHOULAM R; WEIDENFELD J
      CHARACTERIZATION OF THE HYPOTHERMIC EFFECT OF THE SYNTHETIC CANNABINOID HU-210 IN THE RAT - RELATION TO THE ADRENERGIC SYSTEM AND ENDOGENOUS PYROGENS

      Neuropharmacology
    45. ABRAHAMOV A; ABRAHAMOV A; MECHOULAM R
      AN EFFICIENT NEW CANNABINOID ANTIEMETIC IN PEDIATRIC ONCOLOGY

      Life sciences
    46. FRIDE E; BARG J; LEVY R; SAYA D; HELDMAN E; MECHOULAM R; VOGEL Z
      LOW-DOSES OF ANANDAMIDES INHIBIT PHARMACOLOGICAL EFFECTS OF DELTA(9)-TETRAHYDROCANNABINOL

      The Journal of pharmacology and experimental therapeutics
    47. MECHOULAM R; FRIDE E; HANUS L; BENSHABAT S; BARG J; VOGEL Z
      ENDOGENOUS LIGANDS FOR THE CENTRAL AND PERIPHERAL CANNABINOID RECEPTORS

      Journal of neurochemistry
    48. BAYEWITCH M; AVIDORREISS T; LEVY R; BARG J; MECHOULAM R; VOGEL Z
      THE PERIPHERAL CANNABINOID RECEPTOR - ADENYLATE-CYCLASE INHIBITION AND G-PROTEIN COUPLING

      FEBS letters
    49. BARG J; FRIDE E; HANUS L; LEVY R; MATUSLEIBOVITCH N; HELDMAN E; BAYEWITCH M; MECHOULAM R; VOGEL Z
      CANNABINOMIMETIC BEHAVIORAL-EFFECTS OF AND ADENYLATE-CYCLASE INHIBITION BY 2 NEW ENDOGENOUS ANANDAMIDES

      European journal of pharmacology
    50. MECHOULAM R; BENSHABAT S; HANUS L; LIGUMSKY M; KAMINSKI NE; SCHATZ AR; GOPHER A; ALMOG S; MARTIN BR; COMPTON DR; PERTWEE RG; GRIFFIN G; BAYEWITCH M; BARG J; VOGEL Z
      IDENTIFICATION OF AN ENDOGENOUS 2-MONOGLYCERIDE, PRESENT IN CANINE GUT, THAT BINDS TO CANNABINOID RECEPTORS

      Biochemical pharmacology
    51. TAURA F; MORIMOTO S; SHOYAMA Y; MECHOULAM R
      FIRST DIRECT EVIDENCE FOR THE MECHANISM OF DELTA(1)-TETRAHYDRICANNABINOLIC ACID BIOSYNTHESIS

      Journal of the American Chemical Society
    52. MECHOULAM R; VOGEL Z; BARG J
      CNS CANNABINOID RECEPTORS - ROLE AND THERAPEUTIC IMPLICATIONS FOR CNSDISORDERS

      CNS DRUGS
    53. DEFONSECA FR; CALDERON JLM; MECHOULAM R; NAVARRO M
      REPEATED STIMULATION OF D-1 DOPAMINE-RECEPTORS ENHANCES ELTA-8-TETRAHYDROCANNABINOL-DIMETHYLHEPTYL-INDUCED CATALEPSY IN MALE-RATS

      NeuroReport
    54. SCHUEL H; GOLDSTEIN E; MECHOULAM R; ZIMMERMAN S; ZIMMERMAN AM
      EFFECTS OF ANANDAMIDE ON SPERM FUNCTION

      The FASEB journal
    55. GLASER R; ADIN I; MECHOULAM R; HANUS L
      2-METHYL- AND 4-METHYL-DELTA(8)-TETRAHYDROCANNABINOL - CORRELATION OFSPATIAL DISTINCTION WITH CANNABINOID RECEPTOR-BINDING

      Heterocycles
    56. GUIMARAES FS; DEAGUIAR JC; MECHOULAM R; BREUER A
      ANXIOLYTIC EFFECT OF CANNABIDIOL DERIVATIVES IN THE ELEVATED PLUS-MAZE

      General pharmacology
    57. VOGEL Z; BAYEWITCH M; LEVY R; MATUSLEIBOVITCH N; HANUS L; BENSHABAT S; MECHOULAM R; AVIDORREISS T; BARG J
      BINDING AND FUNCTIONAL-STUDIES WITH THE PERIPHERAL AND NEURONAL CANNABINOID RECEPTORS

      Regulatory peptides
    58. WIRGUIN I; MECHOULAM R; BREUER A; SCHEZEN E; WEIDENFELD J; BRENNER T
      SUPPRESSION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY CANNABINOIDS

      Immunopharmacology
    59. JARBE TUC; MECHOULAM R; ZAHALKA J
      DISCRIMINATIVE STIMULUS-FIELD AND OPEN-FIELD EFFECTS OF THE ENANTIOMERS OF 11-HYDROXY-DELTA-8-TETRAHYDROCANNABINOL IN PIGEONS AND GERBILS

      Pharmacology, biochemistry and behavior
    60. WEIDENFELD J; FELDMAN S; MECHOULAM R
      EFFECT OF THE BRAIN CONSTITUENT ANANDAMIDE, A CANNABINOID RECEPTOR AGONIST, ON THE HYPOTHALAMO-PITUTARY-ADRENAL AXIS IN THE RAT

      Neuroendocrinology
    61. SCHUEL H; GOLDSTEIN E; MECHOULAM R; ZIMMERMAN AM; ZIMMERMAN S
      ANANDAMIDE (ARACHIDONYLETHANOLAMIDE), A BRAIN CANNABINOID RECEPTOR AGONIST, REDUCES SPERM FERTILIZING-CAPACITY IN SEA-URCHINS BY INHIBITINGTHE ACROSOME REACTION

      Proceedings of the National Academy of Sciences of the United Statesof America
    62. SMITH PB; COMPTON DR; WELCH SP; RAZDAN RK; MECHOULAM R; MARTIN BR
      THE PHARMACOLOGICAL ACTIVITY OF ANANDAMIDE, A PUTATIVE ENDOGENOUS CANNABINOID, IN MICE

      The Journal of pharmacology and experimental therapeutics
    63. MECHOULAM R; BENSHABAT S; HANUS L; GOPHER A; ALMOG S; MARTIN BR; COMPTON DR; BARG J; VOGEL Z
      ENDOGENOUS LIGANDS FOR THE CENTRAL RND PERIPHERAL CANNABINOID RECEPTORS

      Journal of neurochemistry
    64. BAYEWITCH M; LEVY R; BARG J; MATUSLEIBOVITCH N; SAYA D; HANUS L; BENSHABAT S; MECHOULAM R; VOGEL Z
      A NOVEL LIGAND FOR CANNABINOID RECEPTORS, ARACHIDONYL GLYCEROL, BINDSTO BOTH THE NEURONAL AND PERIPHERAL RECEPTOR FORMS

      Journal of neurochemistry
    65. FRIDE E; MECHOULAM R
      INHIBITION AND SENSITIZATION OF THE CANNABINOID RECEPTOR BY VERY-LOW DOSES OF ANANDAMIDES

      Journal of neurochemistry
    66. PERTWEE R; GRIFFIN G; HANUS L; MECHOULAM R
      EFFECTS OF 2 ENDOGENOUS FATTY-ACID ETHANOLAMIDES ON MOUSE VASA-DEFERENTIA

      European journal of pharmacology
    67. MECHOULAM R; HANUS L; MARTIN BR
      SEARCH FOR ENDOGENOUS LIGANDS OF THE CANNABINOID RECEPTOR

      Biochemical pharmacology
    68. MECHOULAM R; HANUS L; MARTIN BR
      SEARCH FOR ENDOGENOUS LIGANDS OF THE CANNABINOID RECEPTOR

      Biochemical pharmacology
    69. ABULAFI S; STERIN M; LEVIN S; MECHOULAM R
      STRUCTURAL FEATURES AFFECTING CHIRAL DISCRIMINATION OF TERPENE DERIVATIVES ON A CARBAMATED AMYLOSE STATIONARY-PHASE

      Journal of chromatography
    70. SHOHAMI E; NOVIKOV M; MECHOULAM R
      A NONPSYCHOTROPIC CANNABINOID, HU-211, HAS CEREBROPROTECTIVE EFFECTS AFTER CLOSED-HEAD INJURY IN THE RAT

      Journal of neurotrauma
    71. NADLER V; MECHOULAM R; SOKOLOVSKY M
      THE NON-PSYCHOTROPIC CANNABINOID (-(3S,4S)-7-HYDROXY-DELTA-6-TETRAHYDROCANNABINOL 1,1-DIMETHYLHEPTYL (HU-211) ATTENUATES N-METHYL-D-ASPARTATE RECEPTOR-MEDIATED NEUROTOXICITY IN PRIMARY CULTURES OF RAT FOREBRAIN())

      Neuroscience letters
    72. ZIAS J; STARK H; SELIGMAN J; LEVY R; WERKER E; BREUER A; MECHOULAM R
      EARLY MEDICAL USE OF CANNABIS

      Nature
    73. VOGEL Z; BARG J; LEVY R; SAYA D; HELDMAN E; MECHOULAM R
      ANANDAMIDE, A BRAIN ENDOGENOUS COMPOUND, INTERACTS SPECIFICALLY WITH CANNABINOID RECEPTORS AND INHIBITS ADENYLATE-CYCLASE

      Journal of neurochemistry
    74. HANUS L; GOPHER A; ALMOG S; MECHOULAM R
      2 NEW UNSATURATED FATTY-ACID ETHANOLAMIDES IN BRAIN THAT BIND TO THE CANNABINOID RECEPTOR

      Journal of medicinal chemistry
    75. NADLER V; MECHOULAM R; SOKOLOVSKY M
      BLOCKADE OF CA-45(2-METHYL-D-ASPARTATE RECEPTOR-ION CHANNEL BY THE NON-PSYCHOACTIVE CANNABINOID HU-211() INFLUX THROUGH THE N)

      Brain research
    76. LEVIN S; ABULAFI S; ZAHALKA J; MECHOULAM R
      RESOLUTION OF CHIRAL CANNABINOIDS ON AMYLOSE TRIS(3,5-DIMETHYLPHENYLCARBAMATE) CHIRAL STATIONARY-PHASE - EFFECTS OF STRUCTURAL FEATURES ANDMOBILE-PHASE ADDITIVES

      Journal of chromatography
    77. PERTWEE RG; STEVENSON LA; ELRICK DB; MECHOULAM R; CORBETT AD
      INHIBITORY EFFECTS OF CERTAIN ENANTIOMERIC CANNABINOIDS IN THE MOUSE VAS-DEFERENS AND THE MYENTERIC PLEXUS PREPARATION OF GUINEA-PIG SMALL-INTESTINE

      British Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 22:05:46